Q1 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Torrent Pharmaceuticals Limited Q1 FY '22 Earnings Conference Call. We have with us today Mr. Sanjay Gupta, Executive Director, International Business; Mr. Sudhir Menon, Executive Director and Chief Financial Officer; and Aman Mehta, Chief Marketing Officer, India business. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.
Thank you, and hi, good evening, everyone, and welcome to Torrent 1 -- Torrent quarter 1 FY '22 earnings call. At the outset, quarter 1 growth was backed by continued growth momentum in the branded generic market, mainly India and Brazil. The second wave of pandemic impacted the recovery trends across some of the key markets we operate.
Very shortly, in terms of financial performance during the quarter, revenues were INR 2,134 crores, up by 4% on a year-on-year basis. EBITDA was
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |